A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants

by palligoelme@gmail.com | Apr 13, 2026 | Clinical Trials

​ Conditions: HIV Infections Interventions: Drug: VH4770359; Drug: Placebo; Drug: Midazolam Sponsors: ViiV Healthcare Not yet recruiting Conditions: HIV Infections Interventions: Drug: VH4770359; Drug: Placebo; Drug: Midazolam Sponsors: ViiV Healthcare Not yet...

Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

by palligoelme@gmail.com | Apr 13, 2026 | Clinical Trials

​ Conditions: Primary Central Nervous System Lymphoma (PCNSL); Diffuse Large B Cell Lymphoma (DLBCL) Interventions: Drug: Pomalidomide; Drug: PD-1 / PD-L1 monoclonal antibody; Drug: XPO1 inhibitor Sponsors: Beijing Tongren Hospital Recruiting Conditions: Primary...

Physiological Safety and Behavioral Comfort of Swaddle Bathing in Preterm Infants

by palligoelme@gmail.com | Apr 13, 2026 | Clinical Trials

​ Conditions: Preterm Infants Interventions: Other: Swaddle Bathing; Other: Conventional Tub Bathing Sponsors: Chang Gung University of Science and Technology Recruiting Conditions: Preterm Infants Interventions: Other: Swaddle Bathing; Other: Conventional Tub Bathing...

Xpert® Tropical Fever Test on GeneXpert® Edge X System

by palligoelme@gmail.com | Apr 9, 2026 | Clinical Trials

​ Conditions: Malaria Fever; Zika; Dengue Fever; Leptospirosis; Chikungunya Virus Infection Interventions: Diagnostic Test: Xpert Tropical Fever test Sponsors: Cepheid Enrolling by invitation Conditions: Malaria Fever; Zika; Dengue Fever; Leptospirosis; Chikungunya...

CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

by palligoelme@gmail.com | Apr 9, 2026 | Clinical Trials

​ Conditions: Relapsed or Refractory Plasma Cell Neoplasms Interventions: Genetic: CAR 70-BCMA CAR-T; Drug: Fludarabine and Cyclophosphamide Sponsors: The General Hospital of Western Theater Command Not yet recruiting Conditions: Relapsed or Refractory Plasma Cell...

LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL)

by palligoelme@gmail.com | Apr 9, 2026 | Clinical Trials

​ Conditions: Hematologic Neoplasms; Oncologic Disorders Interventions: Other: LLM-Generated Plain-Language Patient Synopsis Sponsors: Technical University of Munich Not yet recruiting Conditions: Hematologic Neoplasms; Oncologic Disorders Interventions: Other:...